Pfizer, Allergan agree to $160 billion merger

Pfizer, Allergan agree to $160 billion merger

By Modern Healthcare  |  November 22, 2015

The boards of Pfizer and Ireland's Allergan on Sunday approved a merger deal worth $160 billion. The deal would create the largest drugmaker by sales.

New tax inversion rules put damper on pending Pfizer-Allergan deal

By Beth Kutscher  |  November 20, 2015

An expected deal between pharmaceutical giants Pfizer and Allergan that's expected to be worth up to $380 a share could become less lucrative under new U.S. Treasury rules designed to diminish the benefits of cross-border transactions.

Healthcare added nearly 45,000 jobs in October

By Modern Healthcare  |  November 07, 2015

The healthcare industry added 44,900 jobs in October. This year, the industry has created almost 407,000 jobs, which almost equals the 410,000 jobs the industry added in 2013 and 2014 combined.

Pfizer expands income eligibility to its free drug program

By Steven Ross Johnson  |  November 05, 2015

Pharmaceutical giant Pfizer said Thursday that it would double the income threshold for patients to be eligible for financial assistance in response to an increasing number of consumers finding it difficult to afford their prescription medicines.

Pfizer completes $15B acquisition of Hospira

By Associated Press  |  September 03, 2015

Drugmaker Pfizer says it has completed its roughly $15 billion purchase of the injectable-drug maker and infusion-device manufacturer Hospira, expanding its product offerings in a growing medical market.

Pfizer says Hospira purchase will close in early September

By Associated Press  |  August 24, 2015

Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion devicemaker Hospira, and says the deal will close in early September. The FTC has ordered Pfizer to sell four drugs in order to preserve competition.

Pfizer sales, earnings still in patent-cliff plunge

By Steven Ross Johnson  |  July 28, 2015

Pharmaceutical giant Pfizer on Tuesday reported continuing declines in sales and earnings as it girds for the loss of patent protection in Europe and Japan of Enbrel, its rheumatoid arthritis drug.

Florida hospital testing new snake anti-venom

By Associated Press  |  July 04, 2015

Florida Hospital DeLand is one of three hospitals in the state testing an experimental anti-venom for coral snake bites. The brightly colored snake rarely bites, but just a drop of its venom is a lethal dose.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.